RecruitingNot ApplicableNCT06872567
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit
Sponsor
North American Science Associates Ltd.
Enrollment
126 participants
Start Date
Oct 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
Eligibility
Min Age: 40 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Corticosteroid Injection and a medical device called genicular artery embolization for people with knee osteoarthritis (knee oa). The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEgenicular artery embolization
genicular artery embolization
DRUGCorticosteroid Injection
Corticosteroid Injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06872567
Related Trials
Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis
NCT067814631 location
Effects of Core Stabilization Exercises in Female Patients With Gonarthrosis
NCT074823321 location
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)
NCT070360031 location
Advanced Brain Imaging-TKA (fMRI-TKA)
NCT074640801 location
Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA
NCT066116181 location